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 Congenital cataract is one cause of childhood blindness
worldwide. It is clinically and genetically a highly heteroge-
neous lens disorder, with autosomal dominant inheritance be-
ing most common. Congenital cataract can occur either as an
isolated anomaly or in association with other ocular anoma-
lies or as a component of multisystemic disorders. Its inci-
dence is estimated to be between 2.2 and 2.49 per 10,000 in-
fants [1,2]. In one-third of the cases worldwide, congenital
cataract has been reported as familial [3,4]. At least 35 loci
and mutations in 15 genes have been identified as being in-
volved in the pathogenesis of various forms of congenital and
developmental cataracts [5].
The eye lens, an avascular organ, is highly dependent on
intercellular communication for volume regulation and meta-
bolic homeostasis [6]. This is achieved by cell-to-cell com-
munication via gap junctions, which are encoded by the
connexin genes. These gap junctions facilitate the exchange
of ions, metabolites, signaling molecules, and other molecules
that have a molecular weight up to 1 kDa between adjacent
cells [7]. In humans, more than 20 genes coding connexins of
varying molecular mass ranging between 25-62 kDa have been
identified. Three of these, connexin 43, connexin 46, and
connexin 50, are expressed in the lens [8]. Mutations in either
connexin 46 or in connexin 50 have so far been linked with
congenital cataract [9,10].
The aim of present study was to identify the mutations in
the connexin 46 (GJA3) gene in seven congenital cataract fami-
lies of Indian origin. Upon sequence analysis of the GJA3, we
identified a heterozygous C260T change resulting in the sub-
stitution of a highly conserved threonine by methionine at
codon 87 (T87M) in the affected individuals of one family
(CC-472). The change cosegregated completely with the dis-
ease phenotype. This is a novel mutation and has not been
reported previously with congenital cataract.
METHODS
Clinical evaluation and collection of genetic material:  The
present study was undertaken in collaboration with Dr. Daljit
Singh Eye Hospital, Amritsar, Punjab (India). The study pro-
tocols adhered to the tenets of the Declaration of Helsinki and
were approved by the institutional review board of Guru Nanak
Dev University, Amritsar. A pediatric ophthalmologist per-
formed a detailed clinical examination on each proband and
selected relatives. The exam included Snellen visual acuity,
A-scan ultrasonography, and slit-lamp examination with pu-
pil dilation. The phenotypes were documented using slit-lamp
photography. A detailed family history and pedigree were re-
corded for each case. In the present study we analyzed seven
congenital cataract families, each of whom had two to five
affected members. Four families had the autosomal dominant
mode of inheritance and three presented with the autosomal
recessive inheritance pattern. After affected and unaffected
family members gave informed consent, 5-10 ml venous blood
was drawn, and DNA was extracted for subsequent molecular
genetic analysis.
PCR and DNA sequencing:  GJA3  (GenBank
NM_021954), located at 13q11 and consisting of a single cod-
ing exon encoding 435 amino acids, was sequenced using pre-
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797viously published primer sequences [11]. Genomic DNA from
two affected and one unaffected individual from each family
were amplified. PCR and sequencing reactions were performed
following conditions detailed elsewhere [12,13]. Electrophore-
sis of purified sequencing reaction products was performed
on 5% urea-polyacrylamide gel on ABI Prism 377 DNA se-
quencer (Applied Biosystems, Foster City, CA), and data was
analyzed using sequence analysis software version 3.4.1 (Ap-
plied Biosystems).
Restriction endonuclease analysis:  The DNA fragment
harboring the mutation was amplified for both affected and
unaffected family members, and PCR products were digested
with NlaIII restriction enzyme following directions given by
the manufacturer (New England Biolabs, Beverly, MA). Re-
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Figure 1. Pedigree of family CC-472 and lens photograph of proband.  A: Pedigree of family CC-472 with two affected individuals: mother
(I:2) and son (II:1). Circle represents females while squares indicate males. Shaded shapes indicate affected individuals. B: Oblique illumina-
tion of phenotype (II:1) showing white spots of different sizes and shapes in the fetal nucleus. C: Optical section showing wide surface opacity
of the fetal nucleus composed of fine white spots. The space between the surface opacity and central white spots is optically empty.
striction digestion products were analyzed on a 2.5% agarose
gel. In addition, 100 unrelated controls from similar ethnic
background were also similarly tested.
RESULTS
 In the present study, four families with autosomal-dominant
congenital cataract and three families with autosomal-reces-
sive congenital cataract were investigated. Each family had 2-
5 affected members with different clinical morphologies (one
family each with pearl box, posterior cortical, granular, ab-
sorbed membranous, and round ball cataract and two autoso-
mal-recessive families with posterior subcapsular type cata-
ract). Mutation analyses of the connexin 46 (GJA3) gene in
these seven families revealed a novel heterozygous mutation
in only one family (CC-472). In this family, a son and his
mother were affected with bilateral congenital cataract (Fig-
ure 1A). The opacities involved both the embryonal and fetal
nuclei separated by a clear space. Fine white spots made up
the opacity of the fetal nucleus (Figure 1B). The embryonal
nucleus was composed of coarse white spots of various sizes
that were round when located toward the center and linear-
shaped in the periphery. There was an optically empty space
between the embryonal nuclear and fetal nuclear opacities.
The peripheral zone outside the fetal nucleus was clear. The
cataract phenotype gave the appearance of a box produced by
the fetal nuclear opacities and pearls by the embryonal nuclear
opacities (Figure 1C). Hence, this phenotype was termed “pearl
box” cataract.
Direct sequencing of GJA3 revelaed a novel heterozy-
gous C>T transition (Figure 2A) at position 260 (c. 260C>T)
in the affected individuals of CC-472 family. It is this transi-
tion that led to the replacement of highly conserved threonine
798 798with methionine at codon 87 (Thr87Met). This substitution
created a novel NlaIII restriction site that segregated com-
pletely with the disease phenotype in this family (Figure 2C).
This nucleotide change was not observed in the 100 control
subjects from similar ethnic background tested by restriction
digestion analysis (data not shown). Testing of six additional
families revealed no disease-linked change or any polymor-
phic change in GJA3.
DISCUSSION
 We report a novel change, T87M in the connexin 46 gene, in
one family (CC-472) who has what we term “pearl box” cata-
ract. The T87M substitution is likely to be disease causative
as it segregated among the affected members only and was
not detected either in unaffected family members or in 100
unrelated controls. The 260C>T substitution observed in the
present study resulted in the replacement of polar amino acid
threonine (T) with nonpolar amino acid methionine (M) at
codon 87 (T87M) localized in the second transmembrane do-
main (M2) of the connexin 46 polypeptide (Figure 3). This is
the first identified mutation that lies within in the second trans-
membrane domain (M2) of the connexin 46 polypeptide asso-
ciated with novel “pearl box” cataract.
A multiple sequence alignment of the amino acid se-
quences of connexin 46 showed that threonine at position 87
is phylogenetically conserved in the second transmembrane
domain of connexin 46 in different species (Figure 4A) and
also in different human α-connexins (Figure 4B). This indi-
cates that the threonine at position 87 in connexin 46 is likely
to be functionally important and the T87M mutation may there-
fore has a detrimental physiological effect. In the connexin 50
(GJA8) gene localized at 1q21, corresponding mutations (P88S
and P88Q) in the second transmembrane domain (M2) result-
ing in zonular pulverulent [14] and lamellar pulverulent cata-
ract [15], respectively, have been reported. Pal et al. [16] fur-
ther reported that P88S mutant connexin 50 abolishes the func-
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Figure 2. Mutation analysis of family CC-472.  A: DNA
sequence of a portion of GJA3, showing the heterozy-
gous 260C>T transition that changes threonine to me-
thionine at codon 87 in affected individual (II:1). B: DNA
sequence electropherogram of unaffected individual (I:1).
C: NlaIII restriction digestion analysis of amplified DNA
at the mutation site. The 308 bp PCR product is cleaved
into four fragments (306 bp, 261 bp, 45 bp, and 2 bp) in
affected individuals (I:2 and II:1) and into two fragments
(306 bp and 2 bp) in unaffected individuals (I:1 and II:2).
799 799tion of the gap junction channel and acts in a dominant nega-
tive manner. In humans, P87S and P87A mutations located
within M2 of the connexin 32 (GJB1) gene have been reported
in association with Schwann cell dysfunction and peripheral
nerve degeneration in X-linked Charcot-Marie-Tooth disease
[17-19]. The authors hypothesized that these mutations (P87S
and P87A) in M2 of the connexin 32 polypeptide may impair
voltage-dependent opening and closing of gap junctions in
electrically excitable tissues. Suchyna et al. [20] have also
demonstrated that in the connexin 26 polypeptide proline at
codon 87 has a function in voltage-gating of gap junctions.
Although, the effect of T87M mutation observed in the present
study on the activity of the connexin 46 has not been directly
tested, we speculate that, like P88S in the GJA8 and other
dominantly inherited mutations reported in different connexins,
this mutation also results in inappropriate association of
connexins and alters the function of endogenous wild-type
connexins in the affected individuals in a dominant negative
way.
Defects in the connexin 46 and connexin 50 genes have
been reported to cause cataract in mice. Point mutations A47C
and V64A in the connexin 50 gene have been reported to re-
sult, respectively, in nuclear opacities (No2) and nuclear with
posterior suture opacities (Aey5) in mice [21,22]. Gong et al.
[23] reported that mice homozygous for disrupted connexin
46 developed nuclear cataracts due to failure in maintenance
of differentiation and of crystallins solubility, while connexin
50 knockout mice had reduced ocular growth along with
nuclear cataract [24,25].Targeted replacement of connexin 50
with connexin 46 in mice has revealed the role of connexin 50
in lens and eye growth and that of connexin 46 in maintaining
differentiation by nonspecific restoration of intercellular com-
munication [26].
The cataract phenotypes that are reported to be linked with
the GJA3 mutations share genotype-phenotype similarities to
some extent, but they also exhibit some differences with re-
spect to the appearance and location of opacities within the
lens. At this point, 12 mutations in GJA3 have been reported
to be associated with autosomal-dominant congenital cataract
in humans involving different domains of connexin 46
polypeptide (Table 1). Most of the cataract phenotypes linked
with mutations in the GJA3 are of nuclear or zonular pulveru-
lent types. The phenotype observed in present study (CC-472
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Figure 3. Schematic diagram of the connexin 46 polypeptide and locations of identified mutations.  Connexin 46 polypeptide (435 amino
acids) has nine structural domains including a cytoplasmic NH2-terminus, four transmembrane domains (M1-M4), two extracellular loops
(E1-E2), a cytoplasmic loop, and a cytoplasmic COOH-terminus (modified figure from Bennett et al. [31]). The relative location of the T87M
mutation (indicated in red) and other reported mutations associated with congenital cataracts in humans are marked.
Figure 4. A multiple sequence alignment of amino acid sequences of
connexin 46 in different species and in different human alpha-
connexins.  Alignment data indicate that threonine is highly con-
served in different species (A) and in different human alpha-connexins
(B). Arrow points to the conserved threonine at position 87, which is
marked in red.
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TABLE 1. REPORTED MUTATIONS IN GJA3 ASSOCIATED WITH DIFFERENT CONGENITAL CATARACT PHENOTYPES IN DIFFERENT FAMILIES
Mutation spectrum of the connexin 46 (GJA3) gene and cataract phenotypes in different congenital cataract families.
801family) is different in its appearance from the earlier reported
types (Table 1) as it appears like pearls in a box (Figure 1B,C).
The differences in the morphologies of cataract phenotypes
associated with mutations in the GJA3 in different families
may be attributed to the action of modifier genes or environ-
mental factors that could affect the expression of the connexin
46 gene and hence resulting cataract types.
In summary, we describe a novel heterozygous T87M mu-
tation in the connexin 46 polypeptide associated with “pearl
box” cataract. On the basis of observed phenotypic as well as
genotypic variability as compared to previously published re-
ports, the present study further expands the genetic and phe-
notypic heterogeneity of congenital cataract.
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